title: Lipid-lowering therapy and long-term survival in heart transplantation.
abstract: The influence of lipid-lowering therapy employing a historic cohort study design was assessed following heart transplantation. Lipid-lowering therapy appears to confer a survival benefit in cardiac transplant recipients who survive beyond the first year.
authors.affiliation: Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana 70121, USA.
authors.forename: D D
authors.initials: DD
authors.lastname: Stapleton
authors.forename: M R
authors.initials: MR
authors.lastname: Mehra
authors.forename: D
authors.initials: D
authors.lastname: Dumas
authors.forename: F W
authors.initials: FW
authors.lastname: Smart
authors.forename: R V
authors.initials: RV
authors.lastname: Milani
authors.forename: C J
authors.initials: CJ
authors.lastname: Lavie
authors.forename: H O
authors.initials: HO
authors.lastname: Ventura
mesh_terms: D000328:Adult; D002784:Cholesterol / Q000097:blood; D015331:Cohort Studies; D005260:Female; D015248:Gemfibrozil / Q000627:therapeutic use*; D016027:Heart Transplantation / Q000401:mortality*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis; D014280:Triglycerides / Q000097:blood
chemical_list: D000960:Hypolipidemic Agents; D014280:Triglycerides; D002784:Cholesterol; D015248:Gemfibrozil